Lv1
20 积分 2024-09-21 加入
Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
1个月前
已完结
A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice
1个月前
已完结
HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg‐positive patients treated with nucleos(t)ide analogues
1个月前
已完结
Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis
1个月前
已完结
Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase
1个月前
已完结
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
1个月前
已完结
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
1个月前
已完结
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
1个月前
已完结
Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients
1个月前
已完结
Incidence and Predictors of HBsAg Loss in Paediatric Patients With Chronic Hepatitis B Undergoing Antiviral Treatment
2个月前
已完结
皖公网安备34019202002308
